Yuyu Pharma Invests in Dalan Animal Health for Global Growth

Yuyu Pharma has announced a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company known for its innovative platform focused on innate immunity. The investment, revealed on December 2, 2025, signifies Yuyu Pharma’s commitment to expanding its presence in the animal health sector, which is experiencing rapid growth globally.

Dalan Animal Health has gained recognition for developing the world’s first USDA-approved vaccine for honeybees. The company is now working on a groundbreaking shrimp vaccine aimed at improving disease management in aquaculture. This investment will enable Dalan to broaden its platform across various species, including poultry, as it seeks to leverage its technology for comprehensive disease prevention while reducing reliance on antibiotics.

Robert Wonsang Yu, Chief Executive Officer of Yuyu Pharma, emphasized the importance of this investment, stating, “Yuyu Pharma is moving decisively into new areas of animal health where scientific innovation can create lasting global impact.” He highlighted that essential species, such as bees and shrimp, play critical roles in food systems and environmental stability. This investment aims to engage with transformative technologies that will shape the future of animal health solutions.

In addition to its focus on Dalan Animal Health, Yuyu Pharma is also expanding its reach within the companion animal sector. The company has made recent investments in VetmAb Bio, which develops species-specific monoclonal antibodies for dogs and cats, and DogPPL, a premium community and wellness platform for U.S. pet owners. These initiatives reflect Yuyu Pharma’s understanding of evolving consumer expectations and scientific advancements in the pet care industry.

“Animal health is becoming a global growth engine, driven by advances in biologics, sustainable aquaculture, and rising demand for high-quality companion animal care,” Mr. Yu added. His vision for Yuyu Pharma is to actively contribute to the development of technologies that will define the future of the animal health market, rather than merely observing its evolution.

Through these strategic investments, Yuyu Pharma is building a diversified portfolio that spans veterinary biologics, sustainable food-system technologies, and innovative models for pet wellness and engagement. Founded in 1941, Yuyu Pharma has a long-standing commitment to advancing healthcare solutions that improve quality of life. As the company pursues its global expansion strategy, it aims to invest in early-stage and high-growth innovators across biotechnology, sustainability, and animal health.

This investment in Dalan Animal Health marks a significant milestone for Yuyu Pharma as it positions itself as a key player in the rapidly evolving landscape of animal health, with the potential to influence practices and innovations across the industry.